Explaining Inflation Reduction Act Generally, the Negotiation Process, and Potential Interactions with Obesity & CVRM Therapeutics
Time: 11:30 am
day: Conference Day Two
Details:
- Outlining the key provisions of the Inflation Reduction Act guidelines related to drug pricing negotiations
- Emphasizing the impact on existing and future drugs to gain a comprehensive understanding of how this can affect pharmaceutical manufacturers with obesity & CVRM portfolio assets as well as other innovative products
